Medical devices and equipmentThe generic EpiPen isn't winning over first responders. They've found cheaper options | STAT
As EpiPen prices soared in recent years, emergency medical responders across the country started to ditch the auto-injectors in favor of regular syringes.
PharmaceuticalsDrug pricing report shows limits of transparency push | The Wall Street Journal
A new Vermont law—the first of its kind in the U.S.—aims to shine a light on the murky world of prescription-drug pricing by requiring manufacturers to justify big increases. But the transparency push has its limits, as seen in the first report that Vermont officials prepared based on the drugmakers' explanations.
Costly drug for fatal muscular disease wins FDA approval | The New York Times
The Food and Drug Administration has approved the first drug to treat patients with spinal muscular atrophy, a savage disease that, in its most severe form, kills infants before they turn 2.
If there's a remedy for rising drug costs, it's not likely to be available to many Americans in 2017. Prescription drug costs for Americans under 65 years old are projected to jump 11.6% in 2017, or at a quicker pace than the 11.3% price increase in 2016, according to consulting firm Segal Consulting.